Spravato® Treatment in Kalamazoo, MI
When Antidepressants Aren’t Enough, SPRAVATO® Offers a New Path Forward
Spravato® is an FDA-approved nasal-spray treatment for eligible adults with treatment-resistant depression. It is prescribed and administered in a certified clinic, with monitoring after every dose.
Spravato®: A Breakthrough in Depression Treatment
Spravato® is an in-clinic prescription treatment for adults whose depression has not improved enough after prior antidepressant treatment. It works through a different pathway than standard oral antidepressants.
Treatment begins with a psychiatric evaluation to confirm the diagnosis, review prior medication trials and screen for safety concerns. If Spravato is appropriate, our team also reviews insurance authorization, appointment frequency and transportation requirements before the first dose.
Each dose is self-administered under clinical supervision. Patients remain at the clinic for required monitoring and must arrange transportation home after treatment.
What We Offer
Spravato® treatment is carefully planned and monitored. Our team provides a calm clinical setting, reviews what to expect before each visit and tracks symptoms and tolerability throughout the course.
If depression has continued despite previous treatment, request an evaluation to learn whether Spravato may be appropriate.
Monitored Sessions
Each Spravato® dose is administered in the clinic. Your blood pressure, comfort and response are monitored during the required observation period.
Flexible Scheduling
We adjust the frequency of your treatments based on your response, making sure you get the right support at the right time.
Spravato® Expertise
Our team follows the FDA-approved Spravato® protocol and required safety procedures for every visit.
Maintenance Transition
We guide you through the initial phase and ongoing maintenance sessions to help sustain long-term improvement.
Mind-Body Support
We help you manage both the emotional and physical aspects of treatment-resistant depression.
Respectful Care
Our environment is designed to help you feel safe, supported and in control throughout your treatment journey.
Commonly Treated Disorders
Major Depressive Disorder (MDD) with inadequate response to at least two antidepressants
Major Depression with acute suicidal ideation or behavior
Persistent feelings of hopelessness or emotional numbness
Severe mood disturbances that haven’t improved with traditional medications
Care That’s Covered and Accessible
We accept major insurance providers, offer out-of-network support, and provide payment plans for uninsured patients.
Take the First Step Toward Relief
If you’ve tried multiple antidepressants without meaningful improvement or are struggling with suicidal thoughts, Spravato® may offer the breakthrough you need.
Spravato® is FDA-approved for adults with treatment-resistant depression and for those experiencing major depressive disorder (MDD) with suicidal thoughts or behaviors. It’s used in combination with an oral antidepressant when other treatments haven’t worked.
Unlike most antidepressants that affect serotonin or dopamine, Spravato® targets the brain’s glutamate system. It helps “reset” how the brain responds to mood and stress by strengthening connections between brain cells. This is why many patients feel relief faster often within the first few doses.
You’ll self-administer the nasal spray in our clinic under medical supervision. After dosing, you’ll rest for about two hours in a private room while we monitor your blood pressure and how you’re feeling. You may feel sleepy, dizzy, or detached, this is normal and usually fades quickly.
No. Due to possible short-term side effects like drowsiness or dissociation, you won’t be allowed to drive after treatment. Please arrange for someone to take you home after each session.
Spravato® is typically given twice a week for the first month, then once a week, and eventually once every two weeks for maintenance. We’ll tailor the schedule based on how you respond to treatment.
Yes, when administered in a clinical setting. It’s FDA-approved and has been safely used by thousands of patients across the U.S. You’ll be closely monitored before, during, and after each session to ensure your safety.
Spravato® may not be right for you if you have uncontrolled high blood pressure, vascular conditions like aneurysms, a history of brain bleeding, or if you’re pregnant or breastfeeding. We’ll do a thorough screening to make sure it’s safe before beginning treatment.
